Related Experiment Video
Updated: Jan 9, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Adult-Onset Reye's Syndrome and the Risks of Low-Dose Aspirin Rechallenge: A Review of Current Literature and Future
Christopher Gibson1, James Noyes1, Myles Goliger1
1Medicine, SUNY Downstate Health Science University, Brooklyn, USA.
Abstract:
Reye's syndrome is a rare encephalopathy with liver involvement correlated with salicylate drug use in the setting of many viral infections, especially influenza B and varicella, which are disproportionately prevalent in pediatric patients. Reye's syndrome has declined markedly since the 1960s due to public health campaigns and the adoption of alternative antipyretics. The risks associated with salicylate use in adult patients who survived childhood Reye's syndrome are unknown. We review the current literature regarding the prevalence of adult-onset Reye's syndrome, cases of recurrence, and low-dose aspirin rechallenge in a patient who reported a childhood history of Reye's syndrome. Much of the available literature on Reye's syndrome in adults is dated, and a confirmatory diagnosis in many of these cases is deemed controversial, as certain diagnostic tests were not performed. The publication of additional rechallenge trials that include documentation of associated symptoms and lab work, as well as confirmation of childhood disease, would greatly facilitate the management of adult patients with a childhood history of Reye's syndrome by providing a confident estimation of the risk associated with low-dose aspirin rechallenge. Given the lack of sufficient data on the risk associated with low-dose aspirin rechallenge, careful evaluation and further research are necessary to define safe protocols for salicylate drug use in adults with a history of Reye's syndrome.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Atherosclerosis III: Management
Factors Affecting Drug Response: Overview
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

